Regional cerebral blood flow in Parkinson's disease with and without dementia

NeuroImage

Volumn 20, Issue 2, 2003, Pages 1309-1319

  Firbank, M J ^a,b   Colloby, S J ^a   Burn, D J ^b   McKeith, I G ^a   O'Brien, J T ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN REGION; CINGULATE GYRUS; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0142074408     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-8119(03)00364-1     Document Type: Article

References (41)

1. Aarsland D., Andersen K., Larsen J.P., Lolk A., Nielsen H., Kragh-Sorensen P. Risk of dementia in Parkinson's disease - a community-based, prospective study. Neurology. 56:2001;730-736.
2. Aarsland D., Laake K., Larsen J.P., Janvin C. Donepezil for cognitive impairment in Parkinson's disease a randomised controlled study . J. Neurol. Neurosurg. Psychiatry. 72:2002;708-712.
3. Abe Y., Kachi T., Kato T., Arahata Y., Tamada T., Washimi Y., Iwai K., Ito K., Yanagisawa N., Sobue G. Occipital hypoperfusion in Parkinson's disease without dementia correlation to impaired cortical visual processing . J. Neurol. Neurosurg. Psychiatry. 74:2003;419-422.
4. Antonini A., de Notaris R., Benti R., de Gaspari D., Pezzoli G. Perfusion ECD/SPECT in the characterisation of cognitive deficits in Parkinson's disease. Neurol. Sci. 22:2001;45-46.
5. Ashburner J., Friston K.J. Voxel-based morphometry - the methods. NeuroImage. 11:2000;805-821.
6. Burn D.J., Rowan E.N., Minett T., Sanders J., Myint P., Richardson J., Thomas A., Newby J., Reid J., O'Brien J.T., McKeith I.G. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Mov. Disord. 18:2003;884-889.
7. Burton E.J., Karas G., Paling S.M., Barber R., Williams E.D., Ballard C.G., McKeith I.G., Scheltens P., Barkhof F., O'Brien J.T. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel based morphometry. NeuroImage. 17:2002;618-630.
8. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl. Sci. 25:1978;638-643.
9. Colloby S.J., Fenwick J.D., Williams E.D., Paling S.M., Lobotesis K., Ballard C., McKeith I.G., O'Brien J.T. A comparison of Tc-99m-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur. J. Nucl. Med. 29:2002;615-622.
10. Edvinsson L., MacKenzie E.T., McCulloch J. Cerebral Blood Flow and Metabolism. 1993;Raven Press, New York.
11. Folstein M.F., Folstein S.E., McHugh P.R. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
12. Gibb W.R.G., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 51:1988;745-752.
13. Holman, B.L., Johnson, K.A., Gerada, B., Carvalho, P.A., Satlin, A., 1992. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. [Errata published in J. Nucl. Med. 33(4), 484, 1992]. J. Nucl. Med. 32, 181-185.
14. Imran M.B., Kawashima R., Awata S., Sato K., Kinomura S., Ono S., Toshioka S., Sato M., Fukuda H. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease a SPECT study using HMPAO and image standardization technique . J. Nucl. Med. 40:1999;244-249.
15. Jagust W.J., Reed B.R., Martin E.M., Eberling J.L., Nelson-Abbott R.A. Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain. 115:1992;521-537.
16. Kantarci K., Xu Y., Shiung M.M., O'Brien P.C., Cha R.H., Smith G.E., Ivnik R.J., Boeve B.F., Edland S.D., Kokmen E., Tangalos E.G., Petersen R.C., Jack C.R. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 14:2002;198-207.
17. Korczyn A.D. Hallucinations in Parkinson's disease. Lancet. 358:2001;1031-1032.
18. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., Fox P.T. Automated Talairach Atlas labels for functional brain mapping. Hum. Brain Mapp. 10:2000;120-131.
19. Launer L.J., Andersen K., Dewey M.E., Letenneur L., Amaducci L.A., Brayne C., Copeland J.R.M., Dartigues J.-F., Kragh-Sorensen P., Lobo A., Martinez-Lage J.M., Stijnen T., Hofman A. Rates and risk factors for dementia and Alzheimer's disease results from EURODEM pooled analyses . Neurology. 52:1999;78-84.
20. Lee A., Harris J. Problems with perception of space in Parkinson's disease a uestionnaire study . Neuro-ophthalmology. 22:1999;1-15.
21. Markus H.S., Costa D.C., Lees A.J. HMPAO SPECT in Parkinson's disease before and after levodopa correlation with dopaminergic responsiveness . J. Neurol. Neurosurg. Psychiatry. 57:1994;180-185.
22. Matsuda H., Kitayama N., Ohnishi T., Asada T., Nakano S., Sakamoto S., Imabayashi E., Katoh A. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J. Nucl. Med. 43:2002;304-311.
23. Mattila P.M., Roytta M., Lonnberg P., Marjamaki P., Helenius H., Rinne J.O. Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment. Acta Neuropathol. 102:2001;160-166.
24. McKeith I.G., Burn D. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurol. Clin. 18:2000;865-883.
25. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N.H., Ballard C., deVos R.A.I., Wilcock G.K., Jellinger K.A., Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) report of the consortium on DLB international workshop . Neurology. 47:1996;1113-1124.
26. McKeith I., Del Ser T., Spano P., Emre M., Wesnes K., Anand R., Cicin-Sain A., Ferrara R., Spiegel R. Efficacy of rivastigmine in dementia with Lewy bodies a randomised, double-blind, placebo-controlled international study . Lancet. 356:2000;2031-2036.
27. McKeith I.G., Ballard C.G., Perry R.H., Ince P.G., O'Brien J.T., Neill D., Lowery K., Jaros E., Barber R., Thompson P., Swann A., Fairbairn A.F., Perry E.K. Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 54:2000;1050-1058.
28. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease . Neurology. 34:1984;939-944.
29. Meltzer C.C., Kinahan P.E., Greer P.J., Nichols T.E., Comtat C., Cantwell M.N., Lin M.P., Price J.C. Comparative evaluation of MR based partial volume correction schemes for PET. J. Nucl. Med. 40:1999;2053-2065.
30. Mentis M.J., McIntosh A.R., Perrine K., Dhawan V., Berlin B., Feigin A., Edwards C., Mattis P., Eidelberg D. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am. J. Psychiatry. 159:2002;746-754.
31. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42:1997;85-94.
32. Pizzolato G., Dam M., Borsato N., Saitta B., Da Col C., Perlotto N., Zanco P., Ferlin G., Battistin L. [99mTc]-HMPAO SPECT in Parkinson's disease. J. Cereb. Blood Flow Metab. 8:1988;S101-108.
33. Richardson M.P., Friston K.J., Sisodiya S.M., Koepp M.J., Ashburner J., Free S.L., Brooks D.J., Duncan J.S. Cortical grey matter and benzodiazepine receptors in malformations of cortical development a voxel based comparison of structural and functional imaging data . Brain. 120:1997;1961-1973.
34. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., Goddard R. CAMDEX - a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry. 149:1986;698-709.
35. Sawada H., Udaka F., Kameyama M., Seriu N., Nishinaka K., Shindou K., Kodama M., Nishitani N., Okumiya K. SPECT findings in Parkinson's disease associated with dementia. J. Neurol. Neurosurg. Psychiatry. 55:1992;960-963.
36. Soonawala D., Amin T., Ebmeier K.P., Steele J.D., Dougall N.J., Best J., Migneco O., Nobili F., Scheidhauer K. Statistical parametric mapping of 99mTc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease normalizing to cerebellar tracer uptake . NeuroImage. 17:2002;1193-1202.
37. Spampinato U., Habert M.O., Mas J.L., Bourdel M.C., Ziegler M., de Recondo J., Askienazy S., Rondot P. (99mTc) HMPAO SPECT and cognitive impairment in Parkinson's disease a comparison with dementia of the Alzheimer type . J. Neurol. Neurosurg. Psychiatry. 54:1991;787-792.
38. Tachibana H., Tomino Y., Kawabata K., Sugita M., Fukuchi M. Twelve month follow-up study of regional cerebral blood flow in Parkinson's disease. Dementia. 6:1995;89-93.
39. Talairach J., Tournoux P. Co-planar Stereotactic Atlas of the Human Brain. 1988;Thieme, Stuttgart.
40. Tiraboschi P., Hansen L.A., Alford M., Merdes A., Masliah E., Thal L.J., Corey-Bloom J. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch. Gen. Psychiatry. 59:2002;946-951.
41. Twelves D., Perkins K.S.M., Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov. Disord. 18:2003;19-31.